Current advances in lipid and polymeric antimicrobial peptide delivery systems and coatings for the prevention and treatment of bacterial infections

ME van Gent, M Ali, PH Nibbering, SN Kłodzińska - Pharmaceutics, 2021 - mdpi.com
Bacterial infections constitute a threat to public health as antibiotics are becoming less
effective due to the emergence of antimicrobial resistant strains and biofilm and persister …

Use of natural products in leishmaniasis chemotherapy: an overview

LFO Gervazoni, GB Barcellos, T Ferreira-Paes… - Frontiers in …, 2020 - frontiersin.org
Leishmaniasis is an infectious parasitic disease that is caused by protozoa of the genus
Leishmania, a member of the Trypanosomatidae family. Leishmaniasis is classified by the …

Therapeutic advances in the topical treatment of cutaneous leishmaniasis: A review

M Azim, SA Khan, S Ullah, S Ullah… - PLoS neglected tropical …, 2021 - journals.plos.org
Cutaneous leishmaniasis has been endemic since decades. Millions of cases are reported
worldwide specially in developing and underdeveloped countries. There are 2 major types …

Natural-product-based solutions for tropical infectious diseases

O Adegboye, MA Field, A Kupz, S Pai… - Clinical microbiology …, 2021 - Am Soc Microbiol
About half of the world's population and 80% of the world's biodiversity can be found in the
tropics. Many diseases are specific to the tropics, with at least 41 diseases caused by …

[HTML][HTML] Advances and challenges in nanocarriers and nanomedicines for veterinary application

SG Carvalho, VHS Araujo, AM Dos Santos… - International journal of …, 2020 - Elsevier
To ensure success in the development and manufacturing of nanomedicines requires forces
of an interdisciplinary team that combines medicine, engineering, chemistry, biology …

Cutaneous/mucocutaneous leishmaniasis treatment for wound healing: classical versus new treatment approaches

P Severino, W Santana, ES Lisboa, VLS Santos… - Microbiology …, 2022 - mdpi.com
Cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (ML) show clinical
spectra that can range from a localized lesion (with a spontaneous healing process) to …

Encapsulation of Citrus sinensis essential oil and R-limonene in lipid nanocarriers: A potential strategy for the treatment of leishmaniasis

JS Santos, JG Galvão, MRC Mendonça… - International Journal of …, 2024 - Elsevier
Leishmaniases, a group of neglected tropical diseases caused by an intracellular parasite of
the genus Leishmania, have significant impacts on global health. Current treatment options …

Nanomedicine in leishmaniasis: A promising tool for diagnosis, treatment and prevention of disease-An update overview

JP Assolini, ACM Carloto, BT da Silva Bortoleti… - European Journal of …, 2022 - Elsevier
Leishmaniasis is a neglected tropical disease that has a wide spectrum of clinical
manifestations, ranging from visceral to cutaneous, with millions of new cases and …

Chitosan-based particulate systems for drug and vaccine delivery in the treatment and prevention of neglected tropical diseases

S Şenel, S Yüksel - Drug Delivery and Translational Research, 2020 - Springer
Neglected tropical diseases (NTDs) are a diverse group of infections which are difficult to
prevent or control, affecting impoverished communities that are unique to tropical or …

Preclinical assessment of ursolic acid loaded into nanostructured lipid carriers in experimental visceral leishmaniasis

JA Jesus, IMO Sousa, TNF da Silva, AF Ferreira… - Pharmaceutics, 2021 - mdpi.com
Ursolic acid, a triterpene produced by plants, displayed leishmanicidal activity in vitro and in
vivo; however, the low solubility of this triterpene limits its efficacy. To increase the activity of …